Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.
about
Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Alosetron use in clinical prac ...... nistration composite endpoint.
@en
Alosetron use in clinical prac ...... nistration composite endpoint.
@nl
type
label
Alosetron use in clinical prac ...... nistration composite endpoint.
@en
Alosetron use in clinical prac ...... nistration composite endpoint.
@nl
prefLabel
Alosetron use in clinical prac ...... nistration composite endpoint.
@en
Alosetron use in clinical prac ...... nistration composite endpoint.
@nl
P2093
P2860
P356
P1476
Alosetron use in clinical prac ...... nistration composite endpoint.
@en
P2093
Brian E Lacy
David L Earnest
Emil Chuang
Jean Paul Nicandro
P2860
P304
1756284818771674
P356
10.1177/1756284818771674
P577
2018-05-08T00:00:00Z